Partnerships in Clinical Trials: Ann Wang of Human Genome Sciences Interview – Video

Video Link: https://www.youtube.com/watch?v=mIdOZfpUzyU

Partnerships in Clinical Trials: Ann Wang of Human Genome Sciences Interview
Last week found us in Hamburg, Germany as a sponsor and presenter at the Partnerships in Clinical Trials (PCT) conference. Stephen Young, who leads Medidata #39;s Insights initiative, presented a case study on our Insights Council and shared metrics and industry benchmarks uncovered through our metrics database. Attendees were particularly interested in the data Steve shared on enrollment trends by global region and were surprised to learn that in the past four years, there has not been much of a push into emerging regions. Steve #39;s presentation also focused on monitoring and opportunities for risk-based monitoring and showed that source document verification (SDV) and on-site monitoring are both on the rise. Steve also shared that typical site monitoring costs are 30 percent of the total clinical trial budget mdash;a tremendous investment for the industry mdash;making a compelling argument for the need to adopt a more efficient risk-based approach. But Stephen #39;s presentation was just one of many insightful discussions at this clinical outsourcing event where pharmaceutical companies, sponsors, contract research organizations (CROs) and other industry leaders addressed minimizing risk through agile clinical development. As PCT came to an end, we had the opportunity to sit down with Ann Wang, vice president of clinical operations at Human Genome Sciences mdash;a biopharmaceutical founded in 1992 that was recently acquired by GlaxoSmithKline mdash;to hear her top PCT takeaways. Check out this video ...From:MedidataSolutionsViews:0 0ratingsTime:03:30More inScience Technology

View original post here:
Partnerships in Clinical Trials: Ann Wang of Human Genome Sciences Interview - Video